Navigation Links
John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
Date:2/16/2011

HACKENSACK, N.J. (February 16, 2011) The Division of Breast Oncology at the John Theurer Cancer Center at Hackensack University Medical Center will host the Eighth Annual Northern New Jersey Breast Cancer Conference on Friday, February 18 from 7:00 am 3:30 pm. This free continuing medical education (CME) event will present highlights from the 34th Annual San Antonio Breast Cancer Symposium, an international scientific symposium for breast cancer basic scientists and clinicians, to tri-state area oncologists, hematologists, other physicians and healthcare professionals.

"Each year, an international gathering of leading breast oncologists attend the San Antonio Breast Cancer Symposium to discuss the latest research and treatment methods in breast cancer," said Stanley Waintraub, M.D., F.A.C.P., Co-Chief of Breast Oncology at the John Theurer Cancer Center. "The Eighth Annual Northern New Jersey Breast Cancer Conference provides area physicians and healthcare professionals an opportunity to learn the latest breast cancer research findings so they can apply these learnings to the clinic."

The conference will take place in Hackensack University Medical Center's Hekemian Conference Center and is worth a maximum of 6.0 AMA PRA Category 1 Credits. Topics to be covered include breast cancer screening policy, conflicting viewpoints in newer treatments for advanced breast cancer, radiation therapy in lymph node involvement, neoadjuvant therapy, clinical trials, genomic & molecular profiling, emerging targeted therapies, and use of hormonal therapies before and after diagnosis.

"Education is paramount in advancing research and providing patients with cutting-edge care," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services at Hackensack University Medical Center. "Collaborating with leading experts from outside institutions is key in delivering the best education and updates to our staff and the local healthcare community."

Featured Speakers at this conference include:

  • Stanley E. Waintraub, M.D., F.A.C.P., Co-Chief of Breast Oncology, John Theurer Cancer Center
  • Freya R. Schnabel, M.D., Professor of Surgery, NYU School of Medicine
  • Mary Elizabeth Cianfrocca, D.O., Feinberg School of Medicine, Northwestern University
  • Lawrence J. Solin, M.D., F.A.C.R., Chairman of Radiation Oncology, Albert Einstein Medical Center
  • Howard A. Burris, M.D., Director of Drug Development, Sarah Cannon Research Institute
  • Edith A. Perez, M.D., Director of Breast Program and Professor of Medicine, Mayo Clinic
  • Adam Brufsky, M.D., Ph.D., Associate Chief of the Division of Hematology/Oncology and Professor of Medicine, University of Pittsburgh
  • Brian Leyland-Jones, M.D., Director, Emory Winship Cancer Institute, Emory University
  • Harold A. Harvey, M.D., Director, Professor of Medicine and Director, Hematology/Oncology Fellowship Program, Milton S. Hershey Medical Center

This CME conference is free and directed primarily for medical oncologists and hematologists, as well as nurses and other healthcare professionals in the oncology field who are interested in the treatment of breast cancer. To register in advance, please contact Bonnie LoGiudice at 201-996-4891 or blogiudice@humed.com.


'/>"/>

Contact: Amy Leahing
amy.leahing@widmeyer.com
646-213-7245
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. Oncology basic research director at John Theurer Cancer Center continues transplantation research
2. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
3. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
4. John Theurer Cancer Center to present innovative research at 2 surgical meetings
5. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
6. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
7. The John Theurer Cancer Center recognizes medical physics team for safety track record
8. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
9. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
10. John Theurer Cancer Center offers breakthrough radiation measurement technology
11. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of ... manage stress and anxiety. , “Buzzies change the way we interact with stress ... Buzzies. , Since its launch date in December 2016, The TouchPoint Solution has sold ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... management and workflow solutions, today named The Resource Group as their 2016 Microsoft ... and partner conference in Newport Beach, CA. The award recognizes The Resource ...
(Date:3/23/2017)... ... 23, 2017 , ... According to the National Sleep Foundation , poor ... the only cause of the sunken-eye look, which can include dark circles or bags ... poor health are likely due to genetics, dehydration, allergies, and losing fat beneath the ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys through ... sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted to ...
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 March ... the US Special Operations Command’s Patriot Award. The award was presented by the ... Force Dagger Foundation for its significant and enduring support to the command. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017   Icertis , the leading ... the cloud, today announced an upgrade to the ... to improve clinical trials contract management. Built on ... the solution speeds up clinical trial contracting while ... (CRO). "The pharmaceutical industry is ...
(Date:3/23/2017)... 23, 2017  Interpace Diagnostics Group, Inc. (NASDAQ: ... integrated commercial company that provides clinically useful molecular ... it has entered into agreements to successfully restructure ... ("RedPath") and concurrently terminate its royalty and milestone ... debt to RedPath amounting to $9.34 million is ...
(Date:3/23/2017)... 2017  Additive Orthopaedics, LLC., an early stage ... kicked off a multi-centered clinical study to measure ... According to Brian McLaughlin , ... structures have already shown tremendous post-operative success and ... wedges from which we have seen evidence of ...
Breaking Medicine Technology: